Måns Rosén

The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months

Björn Wettermark, Niklas Hammar, C. MichaelFored et al. · Pharmacoepidemiology and Drug Safety · 2006 · 1.9K citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +15

The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties

Stephen W. Duffy, Làszló Tabár, Marit Holmqvist et al. · Cancer · 2002 · 433 citations

Medicine, Oncology, Preventive Medicine +17

GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy

Holger J. Schünemann, Reem A. Mustafa, Jan Brożek et al. · Journal of Clinical Epidemiology · 2020 · 383 citations · Full text

Education, Educational Assessment, Educational Measurement +15

Mortality, severe morbidity, and injury in children living with single parents in Sweden: a population-based study

Gunilla Ringbäck Weitoft, Anders Hjern, Bengt Haglund et al. · The Lancet · 2003 · 371 citations

Public Health, Child Health, Pediatrics +14

A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden

Niklas Hammar, Lars Alfredsson, Måns Rosén et al. · International Journal of Epidemiology · 2001 · 254 citations · Full text

Medicine, Cardiology, Internal Medicine +12